Total Payments
$25,622
2024 Payments
$12,992
Companies
8
Transactions
39
Medicare Patients
1,250
Medicare Billing
$266,351
Payment Breakdown by Category
Other$24,444 (95.4%)
Food & Beverage$1,178 (4.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,444 | 14 | 95.4% |
| Food and Beverage | $1,178 | 25 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $25,442 | 30 | $0 (2024) |
| Horizon Therapeutics plc | $47.72 | 2 | $0 (2022) |
| ARGENX US, INC. | $27.21 | 1 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $25.82 | 2 | $0 (2022) |
| Amneal Pharmaceuticals LLC | $21.28 | 1 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $19.95 | 1 | $0 (2022) |
| Xeris Pharmaceuticals, Inc. | $19.85 | 1 | $0 (2022) |
| Eisai Inc. | $18.08 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,992 | 10 | ABBVIE INC. ($12,992) |
| 2023 | $6,651 | 11 | AbbVie Inc. ($6,611) |
| 2022 | $5,863 | 16 | ABBVIE INC. ($5,723) |
| 2021 | $115.69 | 2 | AbbVie Inc. ($115.69) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $101.07 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $101.80 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $109.39 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $18.08 | General |
| Category: Neurology | ||||||
| 11/21/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.85 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $112.47 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $318.75 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: NEUROLOGY | ||||||
| 05/10/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $114.11 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $425.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $109.96 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,275.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2022 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: Immunology | ||||||
| 11/18/2022 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Diabetes | ||||||
| 09/28/2022 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,275.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2022 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,125.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 573 | 14,887 | $366,353 | $148,056 |
| 2022 | 8 | 563 | 5,779 | $245,179 | $100,197 |
| 2021 | 4 | 114 | 137 | $40,909 | $18,098 |
Total Patients
1,250
Total Services
20,803
Medicare Billing
$266,351
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 20 | 14,185 | $184,405 | $69,869 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 169 | 220 | $55,440 | $27,539 | 49.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 151 | 157 | $56,363 | $21,078 | 37.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 89 | 153 | $32,742 | $14,125 | 43.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 55 | 55 | $19,965 | $8,630 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 30 | $5,610 | $2,231 | 39.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 32 | $5,856 | $1,988 | 33.9% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 14 | 23 | $2,484 | $1,334 | 53.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 31 | 32 | $3,488 | $1,262 | 36.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 12 | 5,100 | $66,300 | $24,890 | 37.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 127 | 165 | $41,580 | $21,728 | 52.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 130 | 135 | $48,465 | $18,964 | 39.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 96 | 157 | $33,598 | $11,959 | 35.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 75 | 75 | $27,225 | $11,088 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 58 | $10,846 | $5,127 | 47.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 25 | 25 | $7,525 | $3,290 | 43.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 36 | $6,588 | $1,977 | 30.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 27 | 28 | $3,052 | $1,174 | 38.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 46 | 46 | $16,698 | $7,672 | 45.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 29 | 29 | $10,411 | $4,555 | 43.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 25 | 48 | $10,272 | $3,888 | 37.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 14 | $3,528 | $1,983 | 56.2% |
About Dr. Scott Varga, MD
Dr. Scott Varga, MD is a Neurology healthcare provider based in Dublin, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2017. The National Provider Identifier (NPI) number assigned to this provider is 1528593043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Varga, MD has received a total of $25,622 in payments from pharmaceutical and medical device companies, with $12,992 received in 2024. These payments were reported across 39 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,444).
As a Medicare-enrolled provider, Varga has provided services to 1,250 Medicare beneficiaries, totaling 20,803 services with total Medicare billing of $266,351. Data is available for 3 years (2021–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Dublin, OH
- Active Since 04/21/2017
- Last Updated 04/01/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1528593043
Products in Payments
- QULIPTA (Drug) $16,071
- UBRELVY (Drug) $9,371
- UPLIZNA (Drug) $47.72
- VYVGART (Drug) $27.21
- NURTEC ODT (Drug) $25.82
- RYTARY (Drug) $21.28
- NUPLAZID (Drug) $19.95
- GVOKE PFS (Drug) $19.85
- Leqembi (Drug) $18.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Dublin
Abdelhakim Hussein, M.d, M.D
Neurology — Payments: $382,502
Neurology $382,502
Dr. Punit Agrawal, Do, DO
Neurology — Payments: $41,291
Neurology $41,291
Dr. Preston Eibling, D.o, D.O
Neurology — Payments: $15,266
Neurology $15,266
Dr. Markus Schmidt, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $6,375
Neurology $6,375
Raveen Deol, Md, MD
Neurology — Payments: $1,013
Neurology $1,013
Dr. Brian Fahey, Do, DO
Neurology — Payments: $760.22
Neurology $760.22